Stem cell/bone marrow transplant offers some patients with blood cancers and blood disorders the possibility of a cure, and others a longer period of disease-free survival. Founded in 1972, our Adult Stem Cell Transplant Program is one of the largest and most experienced in the world.
Our stem cell/bone marrow transplant program performs approximately 500 transplants each year and has performed more than 11,600 transplants in the program’s history. This includes more than 5,500 allogeneic transplants and more than 5,100 autologous transplants. This experience makes a difference for our patients.
Our patients' outcomes regularly exceed expected outcomes as established by the Center for International Blood and Marrow Transplant Research, which reports and analyzes outcomes for recipients of allogeneic hematopoietic stem cell transplant. In the most recent report (2022), only 6% of centers achieved this outcome level. Dana-Farber Brigham Cancer Center was the largest center to achieve this outcome.